Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah K Meredith

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Trials|April 16, 2015
Sharing data from clinical trials: the rationale for a controlled access approachMatthew R Sydes, Anthony L Johnson, Sarah K Meredith, et al.
Tropical Medicine and Infectious Disease|September 27, 2024
Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary AnalysisStella M Fabiane, Chen-Yuan Chiang, Sarah K Meredith, et al.
Expert Opinion on Drug Safety|March 11, 2024
T-wave morphology abnormalities in the STREAM stage 1 trialGareth Hughes, William J Young, Henry Bern, et al.
PLOS Global Public Health|February 10, 2026
QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trialGareth Hughes, Elena Frangou, Henry Bern, et al.
BMJ (Clinical Research Ed.)|August 23, 2008
Health related quality of life after combined hormone replacement therapy: randomised controlled trialAmanda J Welton, Madge R Vickers, Joseph Kim, et al.
Trials|September 10, 2014
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trialAndrew J Nunn, I D Rusen, Armand Van Deun, et al.
The New England Journal of Medicine|September 9, 2014
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Angela M Crook, Timothy D McHugh, et al.
BMJ (Clinical Research Ed.)|July 13, 2007
Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal womenMadge R Vickers, Alastair H MacLennan, Beverley Lawton, et al.
BMC Pulmonary Medicine|August 16, 2019
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV statusConor D Tweed, Angela M Crook, Rodney Dawson, et al.
The New England Journal of Medicine|May 3, 2013
Penicillin to prevent recurrent leg cellulitisKim S Thomas, Angela M Crook, Andrew J Nunn, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Trials|April 16, 2015
Sharing data from clinical trials: the rationale for a controlled access approachMatthew R Sydes, Anthony L Johnson, Sarah K Meredith, et al.
Tropical Medicine and Infectious Disease|September 27, 2024
Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary AnalysisStella M Fabiane, Chen-Yuan Chiang, Sarah K Meredith, et al.
Expert Opinion on Drug Safety|March 11, 2024
T-wave morphology abnormalities in the STREAM stage 1 trialGareth Hughes, William J Young, Henry Bern, et al.
PLOS Global Public Health|February 10, 2026
QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trialGareth Hughes, Elena Frangou, Henry Bern, et al.
BMJ (Clinical Research Ed.)|August 23, 2008
Health related quality of life after combined hormone replacement therapy: randomised controlled trialAmanda J Welton, Madge R Vickers, Joseph Kim, et al.
Trials|September 10, 2014
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trialAndrew J Nunn, I D Rusen, Armand Van Deun, et al.
The New England Journal of Medicine|September 9, 2014
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Angela M Crook, Timothy D McHugh, et al.
BMJ (Clinical Research Ed.)|July 13, 2007
Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal womenMadge R Vickers, Alastair H MacLennan, Beverley Lawton, et al.
BMC Pulmonary Medicine|August 16, 2019
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV statusConor D Tweed, Angela M Crook, Rodney Dawson, et al.
The New England Journal of Medicine|May 3, 2013
Penicillin to prevent recurrent leg cellulitisKim S Thomas, Angela M Crook, Andrew J Nunn, et al.
Pageof 2